|
Originally published In Press as doi:10.1074/jbc.M005569200 on August 18, 2000
J. Biol. Chem., Vol. 275, Issue 44, 34493-34500, November 3, 2000
Architecture of Ca2+ Channel Pore-lining Segments
Revealed by Covalent Modification of Substituted Cysteines*
Sheryl E.
Koch,
Ilona
Bodi,
Arnold
Schwartz, and
Gyula
Varadi
From the Institute of Molecular Pharmacology and Biophysics,
University of Cincinnati, College of Medicine,
Cincinnati, Ohio 45267-0828
Received for publication, June 25, 2000, and in revised form, August 17, 2000
 |
ABSTRACT |
The cysteine accessibility method was used to
explore calcium channel pore topology. Cysteine mutations were
introduced into the SS1-SS2 segments of Motifs I-IV of the human
cardiac L-type calcium channel, expressed in Xenopus
oocytes and the current block by methanethiosulfonate compounds was
measured. Our studies revealed that several consecutive mutants of
motifs II and III are accessible to methanethiosulfonates, suggesting
that these segments exist as random coils. Motif I cysteine mutants
exhibited an intermittent sensitivity to these compounds, providing
evidence for a -sheet secondary structure. Motif IV showed a
periodic sensitivity, suggesting the presence of an -helix. These
studies reveal that the SS1-SS2 segment repeat in each motif have
non-uniform secondary structures. Thus, the channel architecture
evolves as a highly distorted 4-fold pore symmetry.
 |
INTRODUCTION |
Calcium entry via voltage-dependent calcium channels
is a key chemical signal responsible for biological events such as E-C coupling, neurotransmitter release, and regulation of gene expression. Although the extracellular space contains high concentrations of
sodium, potassium, and calcium ions, the voltage-dependent calcium channel provides a selective means for a high throughput of
calcium ions. Despite the large pore size of the calcium channel, the
narrowest point being 6 Å (10 10 m) in
diameter (1), the channel is specifically permeable to calcium at
concentrations as low as 1 µM (2). For all calcium channels, the selectivity filter consists of four glutamate residues (3-9), one residing in each of the four motifs, with the exception of
the newly cloned T-type channel family (10-12), which contains two
glutamates (motifs I and II) and two aspartates (motifs III and IV).
There are different models describing calcium movement through the
channel at an approximate rate of 1 × 106 ions per
second. The one-binding site model, first proposed by Almers and
McCleskey (8, 13, 14) and recently reevaluated by Dang and McCleskey
(15) utilizes the concept of charge repulsion to facilitate the
movement of calcium ions through the channel. The multiple-binding site
model (16-20), however, suggests the presence of two calcium-binding
sites of differing affinity, although it is unclear which, if any, of
the four glutamates form the high affinity site(s) and which form the
low affinity site(s). There is general agreement that the four
glutamates do not equally contribute to the binding and subsequent
movement of the calcium ion into the cell (6, 21), however,
voltage-dependent calcium channel topology has not been
experimentally determined.
The experimental procedure known as scanning cysteine accessibility
method (SCAM)1 has been
extensively applied to study short regions of the secondary structure
of membrane bound proteins to elucidate secondary structure (22). SCAM
is based on the fact that known protein secondary structures, such as
an -helix or -sheet, contain amino acids that are exposed to the
extracellular space. The periodicity of these exposed amino acids, as
determined by the secondary structure of the region, provide a means by
which overall secondary structure can be determined. Akabas et
al. (22) demonstrated that by individually changing each amino
acid, in a given segment, to cysteine, then adding sulfhydryl-modifying
compounds, they could determine which amino acids of the acetylcholine
receptor were exposed extracellularly, and subsequently the implied
secondary structure of that region.
Since the first description of application of SCAM to the acetylcholine
receptor (23, 24), many additional proteins have been investigated,
such as the -aminobutyric acid type A receptor (25, 26), dopamine
D2 receptor (27-31), cystic fibrosis transmembrane conductance regulator (32-34), cyclic nucleotide-gated channel (35), ryanodine receptor (36), voltage-dependent
Cl channel (37), and 2-adrenergic receptor
(38). Among these, the most revealing and detailed studies were done on
the potassium channel pore-lining region (39, 40), in which the
secondary structure of the voltage-dependent potassium
channel pore region was described as random coils. Importantly, these
findings were recently confirmed by x-ray crystallographic studies (41,
42), and clearly demonstrated the relevance of this method in
determining unknown secondary structure.
To examine the secondary structure of the voltage-dependent
calcium channel pore, we systematically introduced cysteine mutations within consecutive positions in all four pore-lining segments of a
calcium channel. These mutants were expressed in Xenopus oocytes and their sensitivities to methanethiosulfonate compounds were
determined. Based on the accessibility to sulfhydryl modification, we
established a secondary structure for the pore-lining segments and made
observations that provide an initial spatial arrangement of the
selectivity filter in the pore.
 |
EXPERIMENTAL PROCEDURES |
Scanning Cysteine Mutagenesis of the Human Heart
1C Subunit--
Amino acids that reside within the pore
of the human heart calcium channel (HHT-1) (52) were sequentially
mutagenized to cysteine residues (Fig. 1). This was accomplished by
employing the two-step polymerase chain reaction amplification
method, termed "mega-primer" polymerase chain reaction. The
polymerase chain reaction products containing motif I mutations, T326C,
V327C, F328C, Q329C, I331C, T332C, M333C, E334C, G335C, W336C, and
T337C, were subcloned into the Eco47III
(1526)/ClaI (2663) fragment of the HHT-1 cDNA and
sequenced (52). Fragments from these constructs were then cleaved using
the unique restriction sites MfeI (1732) and ClaI
(2663) and ligated into the full-length HHT-1 cDNA. Substitution by
serine for the endogenous pore cysteine residue, Cys330,
was performed in the same manner as the individual cysteine mutants for
motif I. The motif II mutations, T669C, V670C, F671C, Q672C, I673C,
L674C, T675C, G676C, E677C, D678C, W679C, and N680C, were subcloned
into a BamHI (2498)/BsaAI (4550) cassette of the full-length HHT-1 cDNA and sequenced. These fragments were cut and
ligated into the full-length HHT-1 ClaI (2663) and
AflII (3920) restriction sites. The motif III, A1078C,
L1079C, F1080C, T1081C, V1082C, S1083C, T1084C, F1085C, E1086C, G1087C,
W1088C, P1089C, E1090C, and the motif IV, L1379C, L1380C, F1381C,
R1382C, A1384C, T1385C, G1386C, E1387C, A1388C, W1389C, Q1390C, and
D1391C mutations were subcloned into a fragment of the full-length
HHT-1 cDNA clone, called DE7 (3729/6635) (52). The motif III and IV
mutations were sequenced and ligated into the full-length HHT-1
AflII (3920)/BclI (5720) restriction sites. All
full-length mutant cDNAs were resequenced at the boundaries and at
the mutated site to ensure the desired mutations were present.
In Vitro cRNA Synthesis and Electrophysiological
Measurements--
Human heart 1C and 1C
mutants, 2/ a (53, 54), and human
3 (55-58) were linearized for cRNA synthesis using the
XbaI, XhoI, and NheI restriction
enzymes, respectively. Complementary RNA synthesis was accomplished by
employing the T7 mMessage mMachineTM (Ambion). The
resultant transcripts were quantified spectrophotometrically, diluted
to a final concentration of 1 µg/µl, and verified by
formaldehyde-based agarose gel electrophoresis.
cRNAs were injected into freshly isolated, defolliculated stage V-VI
Xenopus laevis oocytes in an approximate mass ratio of 2:1:1
for 1: 2/ : 3,
respectively. The total concentration of cRNA injected into each oocyte
was 1 µg/µl. After 2-4 days of incubation at 19 °C, in
physiological solution containing (in mM): 96 NaCl, 2 KCl,
1 MgCl2, 1.8 CaCl2, 5 HEPES, 2.5 sodium
pyruvate, 0.5 theophylline, pH 7.5, supplemented with 100 units/ml
penicillin and 100 µg/ml streptomycin, whole cell currents were
recorded using the two-microelectrode voltage clamp technique. The
currents were measured in a solution, containing (in mM):
40 Ba(OH)2, 50 N-methyl-D-glucamine,
1 niflumic acid, 2 KOH, 5 HEPES, titrated to pH 7.4 with
methanesulfonic acid. Voltage and current electrodes had a tip
resistance of 0.5-1.5 M when filled with 3 M KCl.
Oocytes that exhibited a large calcium-activated chloride channel
conductance were injected with 50 nl of 40 mM
K4-BAPTA solution (potassium BAPTA, 10 mM
HEPES, pH 7.05) (59). Whole cell leakage and capacitive currents were
subtracted using the P/4 protocol. Currents were digitized at 1 kHz
after being filtered at 1 kHz. The pCLAMP software (Axon Instruments)
was used for data acquisition (version 5.6) and analysis (version
6.03). The peak current amplitude of wild-type channels was determined
through examining the channels current-voltage relationship (data not
shown). The potential which delivered peak current for the wild-type
was 20.00 ± 5.14 mVs. The voltage pulse was applied every 10 s from a holding potential of 80 mV to a test potential of +20 mV;
the duration of the pulse was 80 ms. The current was determined to have
reached steady-state when there was less than a 10% increase or
decrease in current amplitude after 5 min.
After whole cell Ba2+ currents reached steady-state,
methanethiosulfonate (MTS) compounds (Toronto Research Chemicals, Inc.) were perfused into the bath solution surrounding the oocytes for 2 min
(4 ml/min). The MTS compounds were freshly diluted from a 100 mM stock solution into the 40 mM
Ba2+ solution to a final concentration of 3 mM.
The voltage pulse was applied as described previously. The percent
difference between the control current amplitude and the current
amplitude after the addition of the MTS compound was determined for
each individual oocyte. The results have been expressed as an average
of the decrease in the peak current potential for each mutant.
 |
RESULTS |
To perform SCAM on calcium channels, we made systematic individual
mutations converting each amino acid in the pore-lining segments into a
cysteine residue (except those that are cysteine residues in the
wild-type channel, i.e. Cys330 and
Cys1383) as depicted in Fig.
1. Each of the mutated channels,
expressed in Xenopus oocytes, produced measurable
Ba2+ currents when tested using the two-microelectrode
voltage clamp method. However, several of the mutants did express
smaller currents when compared with wild-type. This behavior was
predominately found in the selectivity filter and in motif II mutants.
Current-voltage relationships for each of the pore mutants and HHT-1
demonstrated that the replaced amino acids caused no significant
changes in the half-activation of the channel or in the peak current
potential (data not shown).

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 1.
Alignment of the pore region amino acid
sequences of the different calcium channel
1 subunits. 11.2
corresponds to the amino acid sequence for the human heart clone
(HHT-1). The amino acids that are not homologous with the
11.2 are highlighted (red). The
gray shaded areas identify which amino acids can be
excessively blocked by the MTS compounds.
|
|
Effect of Endogenous Cysteines on MTS Inhibition--
The native
L-type calcium channel carries cysteine residues at the outer mouth of
the pore, thus treatment of the wild-type channel with
methanethiosulfonates may result in inhibition of the current. In order
to determine whether the endogenous cysteines in the neighborhood of
the pore-lining segments contributed to the inhibition of the calcium
channel, we replaced the three cysteines in the pore region,
Cys330, Cys1383, and Cys1396, with
serines and tested for sensitivity to each of the three MTS compounds.
The HHT-1 channel exhibited mild sensitivity, 20-30% current
reduction, to all three of the MTS compounds. However, the current
reduction of 2C S (C1383S and C1396S) and 3C S (C330S,
C1383S, and C1396S), upon addition of MTSET, was 24 and 14%,
respectively. While showing a moderate decrease in sensitivity, a
two-tailed Student's t test analysis did not reveal a
significant difference between the degree of MTS inhibition for these
channels (Fig. 2A). This also
means that the above cysteine residues are not located in the narrowest
section of the pore. Thus, sulfhydryl modification at these residues
does not impose a sufficient degree of block to prevent the ion
permeation. Testing these mutants with MTSES led to the same pattern of
inhibition as that of MTSET (Fig. 2B). However, MTSEA
provided consistently higher inhibition of the wild-type and mutant
channels than that found for the other two MTS compounds (Fig.
2C). This effect can be attributed to the promiscuous
membrane permeation of this MTS compound (43). As a result, we felt to
preserve the integrity of the channel and because the endogenous
cysteines did not produce significant block, all subsequent mutations
were made in the wild-type HHT-1.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Histograms representing the average current
reduction of wild-type, 2C S, and 3C S through
sulfhydryl-modification by the MTS compounds. For each
Xenopus oocyte expressing either the wild-type or one of the
mutant calcium channels, the peak current amplitude was derived from
individual current traces at the peak potential (determined from
current-voltage relationships) before and after the 2-min perfusion of
the MTS compounds. The difference between the peak current amplitudes
results in the current reduction. The values for the current reduction
were averaged and the data are displayed ± S.E. The names on the
abscissa refer to wild-type, containing the three endogenous
pore cysteine residues, 2C S, containing only one endogenous pore
cysteine residue (Cys330), and 3C S, containing no
endogenous pore cysteine residues. Current reduction is after the
addition of 3 mM MTSET (A), MTSES
(B), or MTSEA (C). The current reductions that
are statistically significantly different (p < 0.05)
from wild-type are indicated by an asterisk (*). The
two-tailed Student's t test was used to determine
statistical significance.
|
|
Feasibility of Reducing the MTS Inhibition--
In previous SCAM
studies, reversible reduction of the disulfide bond formed between the
cysteine residue and the MTS compound using dithiothreitol (DTT) (39,
40) has been shown to occur. However, other studies were unable to
reverse this reaction despite high concentrations of DTT (38, 44-47).
The effect that DTT would have on the modified calcium channel was
unknown. To make an attempt to reverse the reaction of the MTS
compounds, we used four different concentrations of DTT. Histograms
depicting the current remaining after addition of MTSET compound and
the subsequent perfusion of four different concentrations of DTT are
shown in Fig. 3A. When oocytes
expressing the wild-type channel were superfused with a bath solution
containing 3 mM MTSET, current reduction of about 20% was
observed. Upon exchanging the bath solution with different
concentrations of DTT, we observed a slight reversion of current block
at 1 mM concentration, however, we were not able to sustain
this reduction with increasing DTT concentrations (Fig. 3A).
In fact, high concentrations of DTT, 20 and 50 mM,
significantly decreased the current remaining, instead of reducing MTS
block. Since the overall effects of DTT were not substantial, even at concentrations of 1 mM, we concluded that upon disulfide
bond formation the region is sterically hindered, therefore reduction cannot occur.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 3.
Histograms depicting the effects of DTT on
the wild-type (A) and E334C (B)
calcium channels following the application of MTSET. Current
reduction is after a 2-min perfusion with 3 mM MTSET
(black bar) and subsequent 2-min perfusion with various
concentrations, 1, 5, 20, and 50 mM DTT (grey
bar).
|
|
The test of the E334C mutation, a well exposed site for extracellular
attack by all three MTS compounds, confirmed that once the -SH site was
reacted with a bulky MTS compound DTT cannot reduce the S-S bond (Fig.
3B). Upon addition of 5 mM and 50 mM DTT, there was a significant decrease in the current remaining (p < 0.05), suggesting that the integrity of the
channel has been compromised.
Intermittent Sensitivity of Motif I Cysteine Mutants--
Currents
expressed by mutants in which amino acids in the SS2 segment of motif I
were systematically changed into cysteine residues were tested for
block by the MTS compounds. Application of MTSET to mutants in motif I
that represent a stretch of six amino acids in the SS2 segment (TMEGWT,
which includes the MEGW signature sequence for this motif) resulted in
a block of calcium channel currents for every second introduced
cysteine residue (Fig. 4A).
Treatment of the same mutant channels with MTSES exhibited a similar
pattern and percentage of block as that observed for MTSET (data not
shown). The pattern of block that begins at T332C and appears
substantial for every second amino acid, while the intermittent ones
are only slightly blocked, resembles a secondary structure in which
every second position is sterically hindered. This type of structure
can be best described by a -pleated sheet-like arrangement of the
amino acids in this region. The MTSEA compound shows surprisingly high
block with all of the mutants in motif I, again an effect that can best
be explained by the high membrane permeability of this compound (data
not shown). None of the individual motif I SS1 segment cysteine mutant
channels (TVFQCI) exhibited substantial reduction of barium current by
MTSET (p > 0.05) (Fig. 4A). However, Q329C
showed a significant degree of block by both MTSES (36%,
p < 0.04, n = 5) and MTSEA (45%,
p < 0.04, n = 7), possibly suggesting
the presence of an -helix. This latter observation is consistent
with the simulated structural model for Ca2+ channels (48)
and also with that determined by x-ray crystallography for the inner
pore-helix in the KcsA channel (42).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 4.
Histograms representing the average current
reduction for each of the individual cysteine mutants in motif I
(A), II (B), III
(C), and IV (D) through sulfhydryl
modification by 3 mM MTSET. The current reduction was
determined the same as that described for wild-type. The current
reduction for mutants that are statistically significantly different
(p < 0.05) from wild-type are indicated by an
asterisk (*). The two-tailed Student's t test
was used to determine statistical significance.
|
|
Sensitivity of Mutants in Motif II and III to Sulfhydryl
Modification--
Three of the individual cysteine residue
substitutions in the SS2 region of motif II had current inhibited by
MTSET (p < 0.001) (Fig. 4B); E677C, D678C,
and W679C, a pattern resembling a "random coil," because it lacks
the necessary characteristics of defined structures, such as an
-helix or a -sheet. Of these residues, only two in the SS2 region
had currents reduced by MTSES, D678C (42%, p < 0.02, n = 9) and W679C (52%, p < 0.001, n = 8) (data not shown). All of the mutants in the SS2
region, with the exception of T675C, had a high degree of current
inhibition by MTSEA (data not shown), which is consistent with the high
membrane permeability of this compound. From the motif II SS1 mutant
channels, only I673C exhibited significant current reduction by MTSES
(39%, p < 0.004, n = 4) (data not
shown), and none of these channels had currents inhibited by MTSET
(Fig. 4B) or MTSEA (data not shown).
For the individual cysteine mutant channels in the motif III SS2
region, an increased degree of block by MTSET was obtained after amino
acid T1084C. The extent of current block is maximal at W1088C (87%,
p < 0.001), then quickly decreases (Fig.
4C). The same pattern of block was observed upon addition of
MTSES (Fig. 5B). This pattern
is typically assigned a random coil structure. All of the
mutants between T1084C and E1090C were sensitive to inhibition by MTSEA
showing various degrees of block (T1084C, 81% and E1090C, 41%,
p < 0.001-0.04, n = 6-17) (Fig.
5C) without a definable pattern for secondary structures,
again a characteristic that is typical for MTSEA. MTSET application to
the motif III SS1 mutant channels was able to block currents from
F1080C (51%, p < 0.001, n = 8) and
T1081C (42%, p < 0.01, n = 14) (Fig.
4C). Currents from T1081C were also blocked by both MTSES
(46%, p < 0.001, n = 12) and MTSEA
(88%, p < 0.001, n = 9) (Fig. 5,
B and C, respectively), again possibly suggesting
the presence of an -helical turn in this region.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Histograms representing the average current
reduction for each of the individual cysteine mutants in motif III
through sulfhydryl-modification by 3 mM MTSET
(A), 3 mM MTSES (B), or 3 mM MTSEA (C). The current reduction
was determined the same as that described for wild-type. The current
reduction for mutants that are statistically significantly different
(p < 0.05) from wild-type are indicated by an
asterisk (*). The two-tailed Student's t test
was used to determine statistical significance.
|
|
Sensitivity of Mutants in Motif IV to Sulfhydryl
Modification--
The amino acid substitutions from the SS2 region of
motif IV resulted in only two neighboring amino acids (G1386C and
E1387C) which demonstrated large current block by MTSET (66 and 73%,
respectively, p < 0.001, n = 7) (Fig.
4D). Interestingly, the two amino acid positions showed
little or no block (that is significantly greater than wild-type) by
MTSES (data not shown). The mutant channels from positions T1385C to
Q1390C all had large current inhibition upon addition of MTSEA (data
not shown). Most of the amino acid positions in the SS1 region of motif
IV, encompassing a stretch from L1379C to A1384C, were insensitive to
the MTS compounds. Only F1381C had a significant current reduction by
MTSET (38%, p < 0.04, n = 9) (Fig.
4D), while L1380C and F1381C both had currents blocked by
MTSES (34 and 36%, respectively, p < 0.05, n = 5-6) and the current from R1382C was inhibited by
MTSEA (50%, p < 0.02, n = 5) (data
not shown).
Differences in Sensitivity Among the Selectivity Filter
Mutants--
The selectivity filter amino acids for each of the four
motifs should be exposed in the pore vestibule, since these glutamates bind to the calcium ion. All four of the selectivity filter amino acids, E334C, E677C, E1086C, and E1387C, demonstrated significant current reduction upon the addition of MTSET, 61, 62, 41, and 73%,
respectively, in comparison to wild-type (p < 0.03).
The substitutions E334C and E1086C showed currents that were inhibited by MTSES, 64 and 50%, respectively (p < 0.001). In
contrast, barium currents through E677C and E1387C were not
significantly sensitive to sulfhydryl modification by MTSES when
compared with wild-type (20 and 27%, respectively, p > 0.05) (Fig. 6). As expected, all four
selectivity filter amino acids demonstrated significant current reduction upon addition of MTSEA; 79% (E334C), 88% (E677C), 59% (E1086C), and 84% (E1387C) (p < 0.001).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 6.
Histogram demonstrating the difference in
effects between MTSET (black bar), MTSES (white
bar), and MTSEA (grey bar) on the four
selectivity filter amino acid cysteine mutants. The current
reduction was determined the same as that described for wild-type. The
current reduction for mutants that are statistically significantly
different (p < 0.03) from wild-type are indicated by
an asterisk (*). The two-tailed Student's t test
was used to determine statistical significance.
|
|
 |
DISCUSSION |
Accessibility of Endogenous Cysteines in the Pore-lining
Region--
The removal of endogenous cysteine amino acids in the pore
region of the voltage-dependent calcium channel did not
have a significant effect on the inhibition of channel current by the MTS compounds. The three different wild-types tested, HHT-1, 2C S,
and 3C S all had 15-25% block when the MTS compounds were added
to the bath, with the exception of MTSEA which demonstrated a 50%
block on 3C S. This latter observation suggests a conformational change in the channel structure upon removal of the three endogenous pore cysteines. The observed higher degree of block could be a result
of an increase in the size of the pore of the channel or potentially
exposing another endogenous cysteine residue that is hidden in the
native channel conformation.
Sensitivity of Cysteine Mutants to Sulfhydryl
Modification--
The secondary structure of the pore region was
heretofore thought to be uniform for all four motifs. Our present
results, however, indicate that they are strikingly distinct. We
employed the Scanning Cysteine Accessibility Method to decipher the
topology of Ca2+ channel pore-lining segments. The pore
region of motif I, based on the intermittent block by the MTS
compounds, reveals a secondary structure best described as a
-pleated sheet. The pore region of motifs II and III displayed a
sequential block encompassing three and four amino acids, similar to
the structural arrangement which is consistent with the presence of a
random coil, whereas motif IV, exhibits periodicity in its block by the
MTS compounds, strongly suggesting the presence of at least an
-helical turn in this region. Our data supports the findings of
Schetz and Anderson (49) who determined that the motif IV pore region
lacks the amino acids necessary to make a p-bend. Their study indicates that there is a 100% probability of a p-bend in motifs I, II, and III,
which is in agreement with the findings of a -sheet, and two random
coils, respectively. These observations establish structural substance
for the assumed, impaired 4-fold symmetry of the four selectivity
filter glutamates. The high number of conserved amino acids residues in
the pore regions of all known calcium channels lend credence to the
applicability of this data to all calcium channels, with the possible
exception of the low-voltage activated T-type channels.
The size and charge of the MTS compounds are important in analyzing the
results of this study. The positively charged MTSET, even though it is
the largest of the three compounds utilized, is able to block all four
of the selectivity filter amino acids by at least 40%. The negatively
charged MTSES has the same effect on the selectivity filter amino acids
from motifs I and III, however, the results for motifs II and IV
indicate that MTSES does not bind these amino acids. One possible
explanation is that the pore regions of motifs II and IV are deeper in
the membrane than those of motifs I and III, thus these latter two
glutamates may be hindering the MTSES compound from reaching deeper
into the membrane by repulsing the negatively charged compound.
The dramatic decrease of channel current upon addition of MTSEA was
expected. This compound is freely membrane permeable and has the
potential to bind to cysteines from the outside or inside of the
membrane (43). This allows MTSEA to block channel current even if the
introduced cysteine residue is hidden from the bath solution
surrounding the oocyte.
An important structural implication originating from this SCAM study is
the involvement of sequential amino acid residues in high percentage
block in each pore-lining segment. In motif I, six residues, in motif
II and IV, three and two, respectively, while in motif III a stretch of
five amino acids responded to MTS treatment with substantial current
reduction. Therefore, our results are similar to those found for the
voltage-dependent sodium and potassium channels, having
three or more consecutive amino acids demonstrating large block
(greater than 50%). Thus, these residues are structurally part of a
highly distorted 4-fold symmetry that runs quasi-parallel with the
imagined axis of the pore (Fig. 7). Such
an arrangement contradicts an earlier model that assumed the narrowest
point of the pore is at the selectivity filter glutamates. The model
depicted in Fig. 7 does not exclude the possibility that the four
glutamates form the high affinity selectivity filter potentially
coordinating one or more Ca2+ ions. The model does,
however, introduce the possibility that the polypeptide backbone
carbonyl groups coordinate additional Ca2+ ions, thus
supporting the multiple occupancy theory. In this aspect, perhaps the
motif I SS2 segment provides the most important contribution.

View larger version (80K):
[in this window]
[in a new window]
|
Fig. 7.
Model of the calcium channel pore-lining
regions. The predicted secondary structure for each of the
four motifs is demonstrated; a -sheet (I), random coils (II and
III), and an -helix (IV). Cysteine substitutions that do not result
in an excessive blockage by MTS compounds are shown in blue, whereas
those demonstrating large block are in pink. The selectivity
filter amino acids are highlighted in green.
|
|
Topology of the Pore-lining Regions in Voltage-gated
Channels--
An additional purpose of this study was to investigate
the structural relationship between the Na+,
K+, and Ca2+ voltage-gated ion channels. It is
clear that despite the close homology in the pore regions of this
family of channels, the selectivity filters of the individual channels
are able to differentiate between the ions with high fidelity.
Heinemann et al. (50, 51) investigated this principle by
conferring Ca2+ ion selectivity onto the sodium channel.
However, the obverse of this procedure, conferring Na+
selectivity onto the calcium channel, has been unsuccessful. This
indicates that there are more extensive requirements for Ca2+ channel selectivity than just the 4 glutamate
residues. The present study revealed that the secondary structures of
the pore regions of Na+ and Ca2+ voltage-gated
channels are not identical. Furthermore, since a random coil is less
strictly structured than an -helix or a -sheet, the presence of
these more rigid structures may be necessary for the selectivity
observed in Ca2+ channels. Removal of these elements, as in
the experiments by Heinemann et al. (50, 51) results in the
formation of a non-selective ion channel. Therefore, it is plausible to
assume that the secondary structure of the pore-lining regions of
Ca2+ channels is critical to the Ca2+
selectivity and dissecting the structure is key to understanding the
mechanisms by which calcium moves through the pore.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Gabor Mikala for providing the
2C S 1 subunit for these studies and Mark Strobeck
for critically reading the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grants HL07382 and HL22619.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Institute of Molecular
Pharmacology and Biophysics, University of Cincinnati, College of
Medicine, 231 Bethesda Ave., Cincinnati, OH 45267-0828. Tel.:
513-558-2466; Fax: 513-558-1778; E-mail: varadig@email.uc.edu.
Published, JBC Papers in Press, August 18, 2000, DOI 10.1074/jbc.M005569200
 |
ABBREVIATIONS |
The abbreviations used are:
SCAM, scanning
cysteine accessibility method;
HHT-1, human heart calcium channel;
MTS, methanethiosulfonate;
MTSET, [2-(trimethylammonium)ethyl]methanethiosulfonate bromide;
MTSES, sodium (2-sulfonatoethyl)methanethiosulfonate;
MTSEA, (2-aminoethyl)methanethiosulfonate hydrobromide;
DTT, dithiothreitol;
BAPTA, 1,2-bis(2-aminophenoxy)-ethane-N,N,N',N'-
tetraacetate.
 |
REFERENCES |
| 1.
|
McCleskey, E. W.,
and Almers, W.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
7149-7153
|
| 2.
|
Kuo, C.-C.,
and Hess, P.
(1992)
Neuron
9,
515-526
|
| 3.
|
Kim, M.-S.,
Morii, T.,
Sun, L.-X.,
Imoto, K.,
and Mori, Y.
(1993)
FEBS Lett.
318,
145-148
|
| 4.
|
Mikala, G.,
Bahinski, A.,
Yatani, A.,
Tang, S.,
and Schwartz, A.
(1993)
FEBS Lett.
335,
265-269
|
| 5.
|
Tang, S.,
Mikala, G.,
Bahinski, A.,
Yatani, A.,
Varadi, G.,
and Schwartz, A.
(1993)
J. Biol. Chem.
268,
13026-13029
|
| 6.
|
Yang, J.,
Ellinor, P. T.,
Sather, W. A.,
Zhang, J.-F.,
and Tsien, R. W.
(1993)
Nature
366,
158-161
|
| 7.
|
Yatani, A.,
Bahinski, A.,
Mikala, G.,
Yamamoto, S.,
and Schwartz, A.
(1994)
Circ. Res.
75,
315-323
|
| 8.
|
Ellinor, P. T.,
Yang, J.,
Sather, W. A.,
Zhang, J.-F.,
and Tsien, R. W.
(1995)
Neuron
15,
1121-1132
|
| 9.
|
Parent, L.,
and Gopalakrishnan, M.
(1995)
Biophys. J.
69,
1801-1813
|
| 10.
|
Cribbs, L. L.,
Lee, J.-H.,
Yang, J.,
Satin, J.,
Zhang, Y.,
Daud, A.,
Barclay, J.,
Williamson, M. P.,
Fox, M.,
Rees, M.,
and Perez-Reyes, E.
(1998)
Circ. Res.
83,
103-109
|
| 11.
|
Perez-Reyes, E.,
Cribbs, L. L.,
Daud, A.,
Lacerda, A. E.,
Barclay, J.,
Williamson, M. P.,
Fox, M.,
Rees, M.,
and Lee, J.-H.
(1998)
Nature
391,
896-900
|
| 12.
|
Lee, J. H.,
Daud, A. N.,
Cribbs, L. L.,
Lacerda, A. E.,
Perexerzev, A.,
Klöckner, U.,
Schneider, T.,
and Perez-Reyes, E.
(1999)
J. Neurosci.
19,
1912-1921
|
| 13.
|
Almers, W.,
and McCleskey, E. W.
(1984)
J. Physiol.
353,
585-608
|
| 14.
|
Armstrong, C. M.,
and Neyton, J.
(1992)
Annal. N. Y. Acad. Sci.
635,
18-25
|
| 15.
|
Dang, T. X.,
and McCleskey, E. W.
(1998)
J. Gen. Physiol.
111,
185-193
|
| 16.
|
Hess, P.,
and Tsien, R. W.
(1984)
Nature
309,
453-456
|
| 17.
|
Rosenberg, R. L.,
and Chen, X.-H.
(1991)
J. Gen. Phys.
97,
1207-1225
|
| 18.
|
Kuo, C.-C.,
and Hess, P.
(1993)
J. Physiol.
466,
629-655
|
| 19.
|
Kuo, C.-C.,
and Hess, P.
(1993)
J. Physiol.
466,
657-682
|
| 20.
|
Doughty, S. W.,
Blaney, F. E.,
and Richards, W. G.
(1995)
J. Mol. Graph.
13,
342-348
|
| 21.
|
Klöckner, U.,
Mikala, G.,
Schwartz, A.,
and Varadi, G.
(1996)
J. Biol. Chem.
271,
22293-22296
|
| 22.
|
Akabas, M. H.,
Stauffer, D. A.,
Xu, M.,
and Karlin, A.
(1992)
Science
258,
307-310
|
| 23.
|
Akabas, M. H.,
Kaufmann, C.,
Archdeacon, P.,
and Karlin, A.
(1994)
Neuron
13,
919-927
|
| 24.
|
Akabas, M. H.,
and Karlin, A.
(1995)
Biochemistry
34,
12496-12500
|
| 25.
|
Xu, M.,
and Akabas, M. H.
(1993)
J. Biol. Chem.
268,
21505-21508
|
| 26.
|
Xu, M.,
Covey, D. F.,
and Akabas, M. H.
(1995)
Biophys. J.
69,
1858-1867
|
| 27.
|
Javitch, J. A.,
Li, X.,
Kaback, J.,
and Karlin, A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10355-10359
|
| 28.
|
Javitch, J. A.,
Fu, D.,
and Chen, J.
(1995)
Biochemistry
34,
16433-16439
|
| 29.
|
Javitch, J. A.,
Fu, D.,
Chen, J.,
and Karlin, A.
(1995)
Neuron
14,
825-831
|
| 30.
|
Javitch, J. A.,
Fu, D.,
and Chen, J.
(1996)
Mol. Pharm.
49,
692-698
|
| 31.
|
Fu, D.,
Ballesteros, J. A.,
Weinstein, H.,
Chen, J.,
and Javitch, J. A.
(1996)
Biochemistry
35,
11278-11285
|
| 32.
|
Akabas, M. H.,
Kaufmann, C.,
Cook, T. A.,
and Archdeacon, P.
(1994)
J. Biol. Chem.
269,
14865-14868
|
| 33.
|
Cheung, M.,
and Akabas, M. H.
(1996)
Biophys. J.
70,
2688-2695
|
| 34.
|
Cheung, M.,
and Akabas, M. H.
(1997)
J. Gen. Physiol.
109,
289-299
|
| 35.
|
Sun, Z.-P.,
Akabas, M. H.,
Goulding, E. H.,
Karlin, A.,
and Siegelbaum, S. A.
(1996)
Neuron
16,
141-149
|
| 36.
|
Quinn, K. E.,
and Ehrlich, B. E.
(1997)
J. Gen. Physiol.
109,
255-264
|
| 37.
|
Fahlke, C., Yu, H. T.,
Beck, C. L.,
Rhodes, T. H.,
and George, A. L., Jr.
(1997)
Nature
390,
529-532
|
| 38.
|
Javitch, J. A.,
Fu, D.,
Liapakis, G.,
and Chen, J.
(1997)
J. Biol. Chem.
272,
18546-18549
|
| 39.
|
Kürz, L. L.,
Zühlke, R. D.,
Zhang, H.-J.,
and Joho, R. H.
(1995)
Biophys. J.
68,
900-905
|
| 40.
|
Yamagishi, T.,
Janecki, M.,
Marban, E.,
and Tomaselli, G. F.
(1997)
Biophys. J.
73,
195-204
|
| 41.
|
Pascual, J. M.,
Shieh, C.-C.,
Kirsch, G. E.,
and Brown, A. M.
(1995)
Neuron
14,
1055-1063
|
| 42.
|
Doyle, D. A.,
Cabral, J. M.,
Pfuetzner, R. A.,
Kuo, A.,
Gulbis, J. M.,
Cohen, S. L.,
Chait, B. T.,
and Mackinnon, R.
(1998)
Science
280,
69-77
|
| 43.
|
Holmgren, M.,
Liu, Y.,
Xu, Y.,
and Yellen, G.
(1996)
Neuropharm.
35,
797-804
|
| 44.
|
Bénitah, J.-P.,
Tomaselli, G. F.,
and Marban, E.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
7392-7396
|
| 45.
|
Chiamvimonvat, N.,
Pérez-García, M. T.,
Ranjan, R.,
Marban, E.,
and Tomaselli, G. F.
(1996)
Neuron
16,
1037-1047
|
| 46.
|
Pérez-García, M. T.,
Chiamvimonvat, N.,
Marban, E.,
and Tomaselli, G. F.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
300-304
|
| 47.
|
Tsushima, R. G.,
Li, R. A.,
and Backx, P. H.
(1997)
J. Gen. Physiol.
109,
463-475
|
| 48.
|
Guy, H. R.,
and Durell, S. R.
(1995)
Soc. Gen. Physiol. Ser.
50,
1-16
|
| 49.
|
Schetz, J. A.,
and Anderson, P. A. V.
(1993)
Biol. Bull.
185,
462-466
|
| 50.
|
Heinemann, S. H.,
Terlau, H.,
Stühmer, W.,
Imoto, K.,
and Numa, S.
(1992)
Nature
356,
441-443
|
| 51.
|
Heinemann, S. H.,
Schlief, T.,
Mori, Y.,
and Imoto, K.
(1994)
Brazilian J. Med. Res.
27,
2781-2802
|
| 52.
|
Schultz, D.,
Mikala, G.,
Yatani, A.,
Engle, D. B.,
Iles, D. E.,
Segers, B.,
Sinke, R. J.,
Weghuis, D. O.,
Klockner, U.,
Wakamori, M.,
Wang, J.-J.,
Melvin, D.,
Varadi, G.,
and Schwartz, A.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
6228-6232
|
| 53.
|
Ellis, S. B.,
Williams, M. E.,
Ways, N. R.,
Brenner, R.,
Sharp, A. H.,
Leung, A. T.,
Campbell, K. P.,
McKenna, E.,
Koch, W. J.,
Hui, A.,
Schwartz, A.,
and Harpold, M. M.
(1988)
Science
241,
1661-1664
|
| 54.
|
Iles, D. E.,
Lehmann-Horn, F.,
Scherer, S. W.,
Tsui, L.-C.,
Weghuis, D. O.,
Suijkerbuijk, R. F.,
Heytens, L.,
Mikala, G.,
Schwartz, A.,
Ellis, F. R.,
Stewart, A. D.,
Deufel, T.,
and Wieringa, B.
(1994)
Hum. Mol. Genet.
3,
969-975
|
| 55.
|
Collin, T.,
Wang, J.-J.,
Nargeot, J.,
and Schwartz, A.
(1993)
Circ. Res.
72,
1337-1344
|
| 56.
|
Pichler, M.,
Cassidy, T. N.,
Reimer, D.,
Haase, H.,
Kraus, R.,
Ostler, D.,
and Striessnig, J.
(1997)
J. Biol. Chem.
272,
13877-13882
|
| 57.
|
Birnbaumer, L.,
Qin, N.,
Olcese, R.,
Tareilus, E.,
Platano, D.,
Costantin, J.,
and Stefani, E.
(1998)
J. Bioenerg. Biomembr.
30,
357-375
|
| 58.
|
Yamaguchi, H.,
Hara, M.,
Strobeck, M.,
Fukasawa, K.,
Schwartz, A.,
and Varadi, G.
(1998)
J. Biol. Chem.
273,
19348-19356
|
| 59.
|
Stühmer, W.,
and Parekh, A. B.
(1995)
in
Single-channel Recordings
(Sakmann, B.
, and Neher, E., eds)
, pp. 341-356, Plenum Press, New York
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Boda, M. Valisko, D. Henderson, B. Eisenberg, D. Gillespie, and W. Nonner
Ionic selectivity in L-type calcium channels by electrostatics and hard-core repulsion
J. Gen. Physiol.,
May 1, 2009;
133(5):
497 - 509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Dodier, U. Banderali, H. Klein, O. Topalak, O. Dafi, M. Simoes, G. Bernatchez, R. Sauve, and L. Parent
Outer Pore Topology of the ECaC-TRPV5 Channel by Cysteine Scan Mutagenesis
J. Biol. Chem.,
February 20, 2004;
279(8):
6853 - 6862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, S. Sheng, C. J. Perry, and T. R. Kleyman
Asymmetric Organization of the Pore Region of the Epithelial Sodium Channel
J. Biol. Chem.,
April 11, 2003;
278(16):
13867 - 13874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Barreiro, C. R. W. Guimaraes, and R. B. de Alencastro
A molecular dynamics study of an L-type calcium channel model
Protein Eng. Des. Sel.,
February 1, 2002;
15(2):
109 - 122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Boileau, J. G. Newell, and C. Czajkowski
GABAA Receptor beta 2 Tyr97 and Leu99 Line the GABA-binding Site. INSIGHTS INTO MECHANISMS OF AGONIST AND ANTAGONIST ACTIONS
J. Biol. Chem.,
January 18, 2002;
277(4):
2931 - 2937.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|